Trials / Completed
CompletedNCT00916266
Autologous Bone Marrow Stem Cells Transplantation in Patients With Temporal Lobe Epilepsy
Phase 1 Study of Autologous Bone Marrow Stem Cells Transplantation in Patients With Temporal Lobe Epilepsy
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Instituto do Cerebro de Brasilia · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
This research investigates the use of autologous bone marrow stem cells for the treatment of medically refractory temporal lobe epilepsy patients.
Detailed description
The aim of this study is to evaluate autologous bone marrow stem cells transplantation as a safe and potentially beneficial treatment for patients with temporal lobe refractory epilepsy. We are mainly evaluating seizure frequency, hippocampal volume an cognitive performance
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Stem cell transplantation | Transplantations with autologous bone marrow mononuclear stem cells by selective posterior cerebral artery angiography |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2011-11-01
- Completion
- 2012-05-01
- First posted
- 2009-06-09
- Last updated
- 2015-07-31
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00916266. Inclusion in this directory is not an endorsement.